$7.08
-1.26% (Daily)
Market Cap
$557.83M
Revenue
$214.30M
Rank by MCap
#1878
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Joseph Todisco MBA
Headquarters
Berkeley Heights, NJ
Employees
64
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was...
Loading chart…